Intellia Therapeutics Inc (NTLA)
21.17
-0.36
(-1.67%)
USD |
NASDAQ |
Apr 24, 16:00
21.26
+0.09
(+0.43%)
After-Hours: 20:00
Intellia Therapeutics Cash from Financing (Quarterly): 106.48M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 106.48M |
| September 30, 2023 | 19.10M |
| June 30, 2023 | 2.516M |
| March 31, 2023 | 2.221M |
| December 31, 2022 | 505.76M |
| September 30, 2022 | 23.98M |
| June 30, 2022 | 5.895M |
| March 31, 2022 | 47.32M |
| December 31, 2021 | 2.28M |
| September 30, 2021 | 668.68M |
| June 30, 2021 | 7.133M |
| March 31, 2021 | 58.60M |
| December 31, 2020 | 234.09M |
| September 30, 2020 | 0.597M |
| June 30, 2020 | 132.22M |
| March 31, 2020 | 4.864M |
| December 31, 2019 | 19.56M |
| September 30, 2019 | 46.40M |
| Date | Value |
|---|---|
| June 30, 2019 | 6.471M |
| March 31, 2019 | 3.999M |
| December 31, 2018 | 30.16M |
| September 30, 2018 | 2.18M |
| June 30, 2018 | 1.155M |
| March 31, 2018 | 6.72M |
| December 31, 2017 | 142.12M |
| September 30, 2017 | 0.371M |
| June 30, 2017 | 0.446M |
| March 31, 2017 | 0.047M |
| December 31, 2016 | 0.261M |
| September 30, 2016 | -1.854M |
| June 30, 2016 | 170.09M |
| March 31, 2016 | -1.195M |
| December 31, 2015 | -0.456M |
| September 30, 2015 | 66.72M |
| June 30, 2015 | -0.30M |
| March 31, 2015 | 4.328M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
0.597M
Minimum
Sep 2020
668.68M
Maximum
Sep 2021
99.69M
Average
19.56M
Median
Dec 2019
Cash from Financing (Quarterly) Benchmarks
| Moderna Inc | -109.00M |
| Regeneron Pharmaceuticals Inc | -446.10M |
| NeuroMetrix Inc | 1.624M |
| Repligen Corp | 268.13M |
| Pacific Biosciences of California Inc | -81.60M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -93.05M |
| Cash from Investing (Quarterly) | 45.94M |
| Free Cash Flow | -408.07M |
| Free Cash Flow Per Share (Quarterly) | -1.017 |
| Free Cash Flow to Equity (Quarterly) | -94.57M |
| Free Cash Flow Yield | -21.56% |